Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund posted a return of -5.18% gross of fees compared to -3.60% return for the Russell 1000 Growth Index. Stock selection and security allocation led the strategy to underperform during the quarter relative to its benchmark. In addition, you can check the top 5 holdings of the fund to know its best picks in 2022.
Aristotle Atlantic highlighted stocks like Thermo Fisher Scientific Inc. (NYSE:TMO) in the Q3 2022 investor letter. Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific Inc. (NYSE:TMO) is a global company that provides scientific instrumentation, and other laboratory products and services. On November 23, 2022, Thermo Fisher Scientific Inc. (NYSE:TMO) stock closed at $547.29 per share. One-month return of Thermo Fisher Scientific Inc. (NYSE:TMO) was 9.83%, and its shares lost 13.54% of their value over the last 52 weeks. Thermo Fisher Scientific Inc. (NYSE:TMO) has a market capitalization of $214.645 billion.
Aristotle Atlantic made the following comment about Thermo Fisher Scientific Inc. (NYSE:TMO) in its Q3 2022 investor letter:
“Thermo Fisher Scientific Inc. (NYSE:TMO) is considered one of the world’s leaders in serving science. The company makes and distributes analytical instruments, scientific equipment, consumables and other laboratory supplies. Thermo Fisher Scientific operates in four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics and Laboratory Product and Biopharma Services. We see Thermo Fisher Scientific as one of the leading management teams in our coverage both through solid execution and savvy Mergers & Acquisitions (M&A). The company is a diversified provider of research and discovery instruments, tools, consumables, and services, and offers a broad-based play on the increased Research & Development (R&D) spend from the biopharma industry. Thermo Fisher Scientific continues to see organic growth in the high single digits with acquisitions increasing their overall portfolio composition and gaining market share.”
Phovoir/Shutterstock.com
Thermo Fisher Scientific Inc. (NYSE:TMO) is in 20th position on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 92 hedge fund portfolios held Thermo Fisher Scientific Inc. (NYSE:TMO) at the end of the third quarter, which was 93 in the previous quarter.
We discussed Thermo Fisher Scientific Inc. (NYSE:TMO) in another article and shared the top dividend stocks to buy according to billionaire Ken Fisher. In addition, please check out our hedge fund investor letters Q3 2022 page for more investor letters from hedge funds and other leading investors.
Suggested Articles:
- 15 Largest Education Companies in the World
- 12 Best Robotics Stocks To Buy According to Hedge Funds
- 12 Best High Yield Dividend Stocks To Buy
Disclosure: None. This article is originally published at Insider Monkey.
